当前位置: X-MOL 学术Allergy Asthma Clin. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database.
Allergy, Asthma & Clinical Immunology ( IF 2.6 ) Pub Date : 2020-05-27 , DOI: 10.1186/s13223-020-00439-9
Henriette Farkas 1 , Donald Levy 2 , Dylan Supina 3 , Melvin Berger 3 , Subhransu Prusty 4 , Moshe Fridman 5
Affiliation  

In this letter to the editor, we present results of claims data analysis. This claims data analysis supports a hypothesis that in patients with hereditary angioedema due to C1-esterase inhibitor (C1-INH) deficiency, the occurrence and/or symptomatology of coexisting autoimmune disease may be positively influenced by a replacement therapy with plasma derived C1-INH.

中文翻译:

遗传性血管性水肿C1-酯酶抑制剂替代疗法和并存的自身免疫性疾病:索赔数据库中的发现。

在写给编辑的信中,我们介绍了索赔数据分析的结果。该声明数据分析支持以下假设:在因C1酯酶抑制剂(C1-INH)缺乏而导致的遗传性血管性水肿的患者中,血浆衍生的C1-INH替代疗法可能对并存的自身免疫性疾病的发生和/或症状产生积极影响。
更新日期:2020-05-27
down
wechat
bug